ArticleJournal of experimental & clinical cancer research : CR2017

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.

Jiahui Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.